Close

About Us

Kelly E. Caudle, PharmD, PhD, BCPS, FCCP

CPIC Co-PI/Director, Department of Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, TN

Dr. Caudle received her Pharm.D. and Ph.D. from The University of Tennessee Health Science Center and completed an ASHP-accredited PGY2 residency at Le Bonheur Children’s Hospital in Memphis, TN. She is also a board‐certified Pharmacotherapy Specialist.  She started working with CPIC in 2012 and is also currently an affiliate Assistant Professor at The University of Tennessee Health Science Center.

Dr. Caudle oversees all CPIC-related projects and the CPIC guideline development process including the coordination of the guideline writing committees, the guideline evidence reviews, and the writing of the guideline manuscript and supplement. Furthermore, Dr. Caudle is involved in the clinical implementation of pharmacogenetics at St. Jude Children’s Research Hospital. She has published over 50 manuscripts in the area of pharmacogenomics.

Dr. Caudle declares no conflicts of interest.

Teri E. Klein, PhD

CPIC Co-PI
Professor
Department of Biomedical Data Science & Medicine
Stanford University, Stanford  CA

Dr. Klein is the Co-Principal Investigator for CPIC, the PharmGKB, PharmCAT and the Baylor College of Medicine/Stanford University Clinical Genome Resource. She is a Professor of Biomedical Data Science and Medicine (BMIR). She received her PhD in medical information sciences from the University of California, San Francisco and a BA in biology/chemistry from the University of California, Santa Cruz. Prior to becoming the director of the PharmGKB in 2000, Dr. Klein was an Associate Adjunct Professor at UCSF.

Dr. Klein’s area of professional expertise extends over clinical and research pharmacogenomics, the study of how variation in human genetics impacts drug response phenotypes and the underlying basis of collagen genetic diseases. The PharmGKB resource is the premiere repository of curated information about how human genetic variation impacts drug-response phenotypes. We use the contents of PharmGKB to create drug dosing guidelines (CPIC) and new applications in data mining, drug discovery and personal genomics. Dr. Klein is part of NIH’s Pharmacogenomics Research Network and co-founder of CPIC.

Dr. Klein delcares no conflicts of interest.

Mary V. Relling, PharmD

Member and Endowed Chair, Department of Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, TN

Dr. Relling earned her undergraduate B.S. degree from the University of Arizona College of Pharmacy and her doctoral degree from the University of Utah College of Pharmacy.   She completed post-doctoral fellowships with Dr. William Evans at St. Jude and with Dr. Urs Meyer at University of Basel. She joined St. Jude as a faculty member in 1988, and was chair of the Department of Pharmaceutical Sciences from 2003-2020.  She is also a professor at the University of Tennessee in the Colleges of Medicine and Pharmacy.

Her primary interests are in treatment and pharmacogenetics of childhood leukemia and clinical implementation of pharmacogenetic testing. Dr. Relling is part of NIH’s Pharmacogenomics Research Network and co-founder of CPIC, the Clinical Pharmacogenetics Implementation Consortium. She has published over 400 original scientific manuscripts. She was elected to the Institute of Medicine in 2009.

Dr. Relling receives investigator-initiated research funding from Servier. Her spouse is on the board of BioSkryb.

Michelle Whirl-Carrillo, PhD

CPIC Stanford Coordinator and Informatics Working Group Co-Lead
PharmGKB Director Stanford University, Stanford, CA

Dr. Whirl-Carrillo has been part of CPIC since its creation and is co-author of multiple CPIC publications and guidelines.  She contributed to the development of the CPIC levels of evidence and strength of recommendation categories, guideline and allele function SOPs, guideline supporting materials’ content and file formats (e.g. allele definition tables), term and phenotype translation standardization projects and the CPIC database.   Michelle holds a Ph.D. in Biophysics from Stanford University and an S.B. in Biology from MIT.

Dr. Whirl-Carrillo declares no conflicts of interest.

James M. Hoffman, PharmD

CPIC Informatics Co-Director
St. Jude Children’s Research Hospital, Memphis, TN

Roseann S. Gammal, PharmD, BCPS

Clinical Pharmacogenomics Specialist
St. Jude Children’s Research Hospital, Memphis, TN

Dr. Gammal is an Assistant Professor of Pharmacy Practice at MCPHS University School of Pharmacy in Boston, MA. She received her Bachelor of Science degrees in Chemistry and Biochemistry from Worcester Polytechnic Institute and her Doctor of Pharmacy degree from MCPHS University School of Pharmacy in Worcester, MA.  She completed a PGY1 Pharmacy Practice residency at the University of North Carolina Medical Center in Chapel Hill, NC and a PGY2 specialty residency in Clinical Pharmacogenetics at St. Jude Children’s Research Hospital in Memphis, TN. Dr. Gammal is a Board Certified Pharmacotherapy Specialist (BCPS). She started working with CPIC in 2015 and coordinates the development of CPIC guidelines. Dr. Gammal is also the co-founder and lead clinical pharmacist for the Pharmacogenomics Clinic at Brigham and Women’s Hospital in Boston.

Li Gong, PhD

CPIC Scientific Staff
PharmGKB Senior Scientific Curator
Stanford University, Stanford, CA

Dr. Gong is a member of the CPIC scientific staff since 2010, and a co-author on multiple CPIC guidelines, including the NSAIDs, statins and warfarin guidelines. She is also a scientific curator of PharmGKB at Stanford University. Dr. Gong holds a Ph.D. in Molecular Biology and Microbiology from Tufts University and a B.S. in Biology from Peking University.

Dr. Li delcares no conflicts of interest.

Rachel Huddart, PhD

CPIC Scientific Staff
PharmGKB Scientific Curator
Stanford University, Stanford, CA

Dr. Huddart joined CPIC as a scientific staff member in 2017 and is a co-author on several guidelines, including the 2020 opioids guideline and the MT-RNR1/aminoglycosides guideline as well as leading the social media efforts of the CPIC PGx Dissemination Committee. Dr. Huddart is also a scientific curator at PharmGKB based at Stanford University. She has a PhD in Genetic Engineering and a BSc (Hons) in Biological Sciences, both from the University of Edinburgh, UK.

Dr. Huddart delcares no conflicts of interest.

Sarah Morris, PharmD

Clinical Pharmacogenomics Specialist
Department of Pharmaceutical Sciences
St. Jude Children’s Research Hospital, Memphis, TN

Dr. Morris earned her B.S. degree from the University of Notre Dame and her doctoral degree from the University of California San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences. She completed her PGY1 at Stanford Health Care and PGY2 in Clinical Pharmacogenomics at St. Jude Children’s Research Hospital. Dr. Morris declares no conflicts of interest.

Katrin Sangkuhl, PhD

CPIC Scientific Staff
PharmGKB Senior Scientific Curator
Stanford University, Stanford, CA

Dr. Sangkuhl has been a member of the CPIC scientific staff since 2010 and is a co-author on numerous CPIC guidelines, including the TCA, SSRI, and atomoxetine guidelines. She has contributed to CPIC projects such as the Term Standardization and the Standardization of CYP2D6 Genotype to Phenotype Translation. Dr. Sangkuhl is also a scientific curator at PharmGKB, based at Stanford University. She holds a Ph.D. in Biochemistry from University Leipzig, Germany.

Dr. Sangkuhl delcares no conflicts of interest.

Ryan Whaley

CPIC Developer
PharmGKB Co-Technical Lead
Software Developer, Stanford University, Stanford, CA

Ryan is a software developer in the Department of Biomedical Data Science at Stanford UniversityHe is a Java developer with a background in database administration and project management and has been with at Stanford since 2007. Ryan received his BS in Computer Science and Mathematics at the University of Iowa and then went on to become the database administrator and senior software developer for the Department of Internal Medicine at the University of Iowa Hospitals & Clinics.

Mr. Whaley declares no conflicts of interest.

Mark Woon

CPIC Developer
PharmGKB Co-Technical Lead
Software Developer, Stanford University, Stanford, CA

Mark has assisted in the development of the CPIC project.  He is the co-technical lead at PharmGKB and has been with PharmGKB since 2001. He received his BSE in computer science from Princeton University.

Mr. Woon declares no conflicts of interest.